CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 56 enrolled
Drug / intervention
Intraperitoneal Ropivacaine (AIR) +1 moredrug
Likely dose
Intraperitoneal Ropivacaine (AIR) 2 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01480089
NCT01480089Phase 4Completed
CompareCT.gov

Surgical Pain Control With Ropivacaine by Atomized Delivery

Loyola University·interventional·Posted Nov 28, 2011·Updated Jul 27, 2016

In Brief

A Phase 4 clinical trial evaluating Intraperitoneal Ropivacaine (AIR) and Atomized Intraperitoneal Saline (AIS) for Pain. Completed, enrolled 56 participants across 1 site.

Detailed Summary

The purpose of this trial is to determine the effect of spraying a local anesthetic called Ropivacaine (numbing medicine) into the abdominal cavity prior to surgery. Ropivacaine is a local anesthetic used to block pain in the body. There are studies showing that Ropivacaine decreases the pain of surgery with minimally invasive (laparoscopic) appendix and gallbladder removal but has not been tried in robotic pelvic surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 28, 2011
Enrollment StartNov 1, 2011
Primary CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 14.6 years ago

Interventions

Intraperitoneal Ropivacaine (AIR)drug

Ropivacaine 2 mg/kg per lean body mass up to no more than 200mg total dose will be atomized and delivered into the peritoneal cavity at the completion of surgery.

Atomized Intraperitoneal Saline (AIS)drug

Atomized saline will be administered to the peritoneal cavity at the completion of surgery.